Laurent Pharmaceuticals
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1010 Rue Sherbrooke O Suite 2401, Montre...Phone Number
(514) 513-2252Website
www.laurentpharma.comRevenue
<$5 MillionIndustry
About Laurent Pharmaceuticals
Laurent Pharma is a clinical stage biotech company dedicated to developing treatments for complex conditions resulting from an unbalanced immune-inflammatory response. The company focuses on the modulation of cell membrane lipids and has over 10 years of clinical development experience with its drug candidate, LAU-7b, currently in Phase 2 clinical trials. Laurent Pharma aims to address high unmet medical needs by targeting multiple molecular pathways to treat degenerative conditions. Their intended clients include healthcare providers and patients seeking innovative therapies for challenging medical issues.Explore more
Laurent Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Laurent Pharmaceuticals
Compare insights from companies similar to Laurent Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Laurent Pharmaceuticals Tech Stack
A closer look at the technologies used by Laurent Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Laurent Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Laurent Pharma is a clinical stage biotech company dedicated to developing treatments for complex conditions resulting from an unbalanced immune-inflammatory response. The company focuses on the modulation of cell membrane lipids and has over 10 years of clinical development experience with its drug candidate, LAU-7b, currently in Phase 2 clinical... Read More
